{"name":"Ethypharm","slug":"ethypharm","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"1969-01-01","label":"Aristospan first approved","drug":"Aristospan","drugSlug":"triamcinolone-hexacetonide","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Aristospan","genericName":"TRIAMCINOLONE HEXACETONIDE","slug":"triamcinolone-hexacetonide","indication":"Alopecia areata","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Fentanyl Ethypharm","genericName":"Fentanyl Ethypharm","slug":"fentanyl-ethypharm","indication":"Moderate to severe pain (acute or chronic)","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Placebo (for baclofen)","genericName":"Placebo (for baclofen)","slug":"placebo-for-baclofen","indication":"Treatment of spasticity","status":"phase_3"}]}],"pipeline":[{"name":"Aristospan","genericName":"TRIAMCINOLONE HEXACETONIDE","slug":"triamcinolone-hexacetonide","phase":"marketed","mechanism":"Glucocorticoid receptor","indications":["Alopecia areata","Discoid lupus erythematosus","Keloid scar","Lichen planus","Lichen simplex chronicus"],"catalyst":""},{"name":"Fentanyl Ethypharm","genericName":"Fentanyl Ethypharm","slug":"fentanyl-ethypharm","phase":"phase_3","mechanism":"Fentanyl is a synthetic opioid agonist that binds to mu-opioid receptors in the central nervous system to produce analgesia and sedation.","indications":["Moderate to severe pain (acute or chronic)","Cancer pain"],"catalyst":""},{"name":"Placebo (for baclofen)","genericName":"Placebo (for baclofen)","slug":"placebo-for-baclofen","phase":"phase_3","mechanism":"Placebo does not have a pharmacological effect.","indications":["Treatment of spasticity"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQeUQtbWdnOHJSUnBlTkdlRUktNklNRndDcHhESHJvLTNjNEhCaUF2R1F4R3lCbTUxVTZlQjVzMEhTZGFHb2pTbmIzOTdTZ2Z0ejlrRGNxVklZZHYxcmpuejl1d3JyX24tN3hISC04NGNac1Y1c3lsVWhVZ0RoVDk1aXV1M2N2Nkw2YmxwUkI2ZFVIVk4xRDFwaVhrajFaVmY2ZExveUh1dTc5SG9YYk1kMGdHVi13TEZydzJTODcwd0U?oc=5","date":"2025-09-22","type":"deal","source":"GuruFocus","summary":"Opioid Kingpin for Sale? €1 Billion Ethypharm Deal Could Shake U - GuruFocus","headline":"Opioid Kingpin for Sale? €1 Billion Ethypharm Deal Could Shake U","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOdzJoQnZGcGRRX204RkRhYVBXVHNRelpyTE11WldRblpHUEtGSFBWZFQzZ0VUd21ReEdIRXJFakkzU19wUTRqb3ExSFFzYjh2Mm1YdE8yNmtjcVFYMUZPRklScU5JTzNXZW5remxMaEJHOFQ2SUdDUHVCQW5OWGdvNGFBcWVQT2JvQllHa0RTdW5SN2paQ21pcFlxa3pmc2pfandaZWM0Y1AyYk94YVpJ?oc=5","date":"2025-09-22","type":"pipeline","source":"investorsinhealthcare.com","summary":"France: PAI said to be readying sale of Ethypharm - investorsinhealthcare.com","headline":"France: PAI said to be readying sale of Ethypharm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxPbk13SVJoRmFmM01mVXRuV2o5RUsxZEsxZTBQbE5TMDQ5a0FHVktJZVN0T1lOZ2c1N291dzdMQ25Lck1YTldmTTFwSGdSaURPZUtibG55YllWQUpJbGcxM3BpWG12cEgta0hxR3otRzh1N1NQMnJ6ZEltTFpwa1ZBOUxiUnZWS2FONTNkX1JJOV9VVDhMUXBmUlU3WnAxa0o1R2lzNUszZUlndWNuWXlONk16MVZpa3RrZTBZVk5aRU94d25yRGJkQjlzRUNudmR4NUpxRWsxSmdyVUE?oc=5","date":"2024-10-04","type":"pipeline","source":"PR Newswire","summary":"Ethypharm announces the appointment of Éric CHEVALIER as Group Human Resources Director - PR Newswire","headline":"Ethypharm announces the appointment of Éric CHEVALIER as Group Human Resources Director","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNYl9nR3dJalMza0Nmc2xDd0pnX1FZc1RBODBLYVpIRF9LSHgtMF9EWWMxbFJJazhsTDJWUzQweEVRekM5Zjc4NklaNEZVYWdtazAzV0gwUklyeGUwUXhqS0RfblB0TXJHbnVRaV9PN2VCdVMwMllYMEZqWHNuRXE5UXZXbk9mN0M0ckxYLV9ORW9uRmxoYlQ3UmE5UEtCb0hxcHJhbUgzLWw1Z2Q4OUZMcEtfZXU?oc=5","date":"2024-06-13","type":"pipeline","source":"PR Newswire","summary":"Ethypharm expands its Mesalazine (Etiasa®) Portfolio in China - PR Newswire","headline":"Ethypharm expands its Mesalazine (Etiasa®) Portfolio in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQbFlZejIxZjVvRjZUNDUxZF9FMW5Lb19aMXp0YmJ1b09hQWRjcjkzaWFFRGlOR1l0UVF3VEZTOTNUVXhWN0NXdGttTy1qMGVvY25UU1dQcTdrOW9RMmVaRXFBaU4zTTRocmxPaXVubGdMYTE3Nnl0Q2ZnTVlKcE0tZ1RFOVNIVHZrQTRPUUJFU2NQNk5ONEZ3V2piMW4yejItSzFtUHQ4Yk1IMmlUYUE?oc=5","date":"2023-04-27","type":"pipeline","source":"biv.com","summary":"B.C. government can sue opioid companies in B.C. Supreme Court - biv.com","headline":"B.C. government can sue opioid companies in B.C. Supreme Court","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxQdDdFTHpieW9JOENSR04zM0xTSTdoQ3AwR2g0R1NKNHBLcGw3eUxqd0FkZnBZWGwwSDNXNjU4VkhmSjNFS3FCT3ZFODF4cXh2TVZNYmNZQTZzZHllVUo1a3lJclVpak5uUERZX3dnamlWaEJ1OHJlOFB0Q0V3eWk4TTB4Tm92WWtVWGdmdTZNemhVcklEREpBV2wyeHZBM0xFTWhMZ250UGt1T0sxWnpzT3VYNUJBQ0xFYS1hYjlBVmg5WmMzNUFwQUZwcEV1dkNNY0g0Zy1mX2tTU2pXNkx0WG8tR2loRzV4bENEMGZRMTFIZlB2WTlUeElzRFg2amgwNVRNNXVn?oc=5","date":"2021-06-18","type":"deal","source":"PR Newswire","summary":"Ethypharm to acquire Altan Pharma, entering the Spanish market and enhancing its Critical Care portfolio and R&D pipeline - PR Newswire","headline":"Ethypharm to acquire Altan Pharma, entering the Spanish market and enhancing its Critical Care portfolio and R&D pipelin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE9jN1NLTkRTTUItZmpoUXQ2MWdUckttTk1yR29uNlRvLWdRSWYwZkdmRTdwUVd5M25DaGtuNHNVbUtUX21JUkNITkM3Q3lOa0JpUHNReDQtOHRGcHl1TThUUXdUWFNraEt3cDc0OFlWXzlrUVdSTm45MmE0c1pDWFE?oc=5","date":"2021-06-18","type":"pipeline","source":"RTE.ie","summary":"Malin's Altan Pharma to be bought by Ethypharm - RTE.ie","headline":"Malin's Altan Pharma to be bought by Ethypharm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxNLWhoRk9wZ2JUckdxSGJuajRWR2JuNi0wY1hrcERpUjlUUElaUzU1TVE4ajFTa2RoaU1rYnMxb09iUlpHYndFNjhtRGR5eTREN0dVSDRTcS1Sa0RKMVpKRHF0Wncyam9OT280VnBRdktZVjB5V0F0b3o5dFJuWTF5MlkzYzVrX3RDVlRUMWREM2JpZG9kUXY0MElOMkRlS1FvYjNvcDJUNHNOeENBRzlVRDdyMjh0WF95VFpsRXduMkFUQ2NFTFZIVUd4M0FqRnM4TjBJamRkbERabnpHTEVGZ2lvVmZMX0M2eUxVSGJzZkFTYk9FY3Mxak14Z2dNVDY0N3RfdmtkNGl3djhjQlFvUGoybWNGaEk?oc=5","date":"2020-12-18","type":"deal","source":"proactiveinvestors.com","summary":"Medexus in exclusive license deal with Europe’s Ethypharm to register and commercialize Triamcinolone Hexacetonide in US - proactiveinvestors.com","headline":"Medexus in exclusive license deal with Europe’s Ethypharm to register and commercialize Triamcinolone Hexacetonide in US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQU2l3dEwtUGVqM2dIbVdYM05vZUhoQ3I5ODloNU45enQ1emZYRThQQ3VRbzlyQXYza2FpMWt6RUt2UFQyU3F6MGVmeDBzNmJxQkk4alVpR1FlV083R0ZXekhYaTN5WFotYV9nUlk4SXUxQ1FiSzlTaWN5M2Y2ZVBFVHczUjJuay1PYnNjdTlxaDBmcXVIM3Y4SE43VzVZeTM5TUc2dERsNmVVeERkOUp3V1Y3T09DMmtIUzBpLVVCZHZKNkJi?oc=5","date":"2019-03-19","type":"pipeline","source":"PR Newswire UK","summary":"Sasa Leskovsek Joins the Ethypharm Group as Chief Scientific Officer - PR Newswire UK","headline":"Sasa Leskovsek Joins the Ethypharm Group as Chief Scientific Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQUHlMZ2lmRjhmRlpEa0RMa1lfT2NfODdGd3lrOGJBY2dTVTZBbmFkZzBfeGJpdEpPWTF5WkNIbGlIVU9Fc1lLekJzWDN3bFEyOWtzelVIbWgtOGVkUzRaZVlYUWE1OWcxS1pYSkJieWp1eHJqNER4ZVlPeGJhTW1zdmdNeXBlUWZ3QkZyeDdkRQ?oc=5","date":"2017-01-23","type":"deal","source":"European Pharmaceutical Review","summary":"French drug developer Ethypharm acquires UK-based Martindale Pharma - European Pharmaceutical Review","headline":"French drug developer Ethypharm acquires UK-based Martindale Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOLVp0Nm5PLTNBOWZwRi1TV1RQLU5RUTNja09MbUFnVkpFRE1tdFZEOHdPVi1zWUhRWllQeThiMlg3cC1KRk1fdlJwQkc5bndWMDB2ekdzT2lTTUduMmRtUWVOY1RRWjNnNW8wRlF4T0IyX0RheEMwdzFtNEtsLVFYRGNxVlJvc3lGTU9zeDVOMHFVRjBOU3RobHpR?oc=5","date":"2017-01-23","type":"deal","source":"PharmaTimes","summary":"France’s Ethypharm to buy UK speciality pharma Martindale - PharmaTimes","headline":"France’s Ethypharm to buy UK speciality pharma Martindale","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE16VnJXWDJKTGl5SG9EVHU4NjlzYkhnU2JkazZiZGRyVGcwWnhhZks5bFVqb2syOGR5TWFmdXNxcVJmY2RnclhkemdQVnVNa3dQeFI3X1N4bFg3V1lrYVNFbTNhNUo3WEFUc3hLWnRvd2hlVi1YQmc?oc=5","date":"2017-01-19","type":"deal","source":"Genetic Engineering and Biotechnology News","summary":"Ethypharm Buying Martindale Pharma - Genetic Engineering and Biotechnology News","headline":"Ethypharm Buying Martindale Pharma","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"marketed":1,"phase_3":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}